SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (6742)5/13/1999 12:11:00 AM
From: VLAD  Read Replies (1) of 7041
 
Claude,

<<Neither Zonagen nor Schering-Plough would release the results of the tests that prompted the delay in the drug application.>>

This is a quote from the AP press release on May 11.

Can you please explain to us WHY we can't be informed of the results of the tests that prompted the one year delay in the drug application? We just want to see the hard science and facts on Vasomax. What has been going on for the past two years that requires another year to rectify itself? What does Zonagen have to lose by informing the investors with the hard cold facts? Aren't they required by SEC regulations to reveal information of such significance to the investing public? Isn't Zonagen a publically traded company?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext